APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Cold Plasma

Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.

Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.

Selected research

Market Outlook & Growth Opportunities

Global Medical Cold Plasma Market Outlook and Growth Opportunities 2026

27 December 2025193 pages

Choose your research edition.

Industry ResearchMedical Cold Plasma Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Cold Plasma Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Medical Cold Plasma Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Cold Plasma Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Cold Plasma Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Cold plasma is generated by applying energy to a gas, which makes the gas molecules or atoms lose their outer electrons and become ionized. It is comprised of a reactive mix of electrons, ions, excited atoms, and molecules – reactive species (e.g. O3, NO, NO2, etc.), UV radiation, and heat. Cold plasma is maintained at temperatures below 40°C, which unlike hot plasma enables it to be applied to living organisms.

Cold plasma in medicine has been shown to inactivate or reduce bacteria, fungi, viruses, spores and allergens, odor, and harmful molecules very efficiently. Extensive research has shown that the concentration and composition of cold plasma components can vary significantly for different plasma sources. It is this ability to modify the cold plasma for specific purposes that makes it possible to design a unique cold plasma technology for many different medical applications. Multiple studies show its use in the field of dentistry, implantology, dermatology, oncology, and as a treatment for antibiotic-resistant strains of bacteria.

The global Medical Cold Plasma market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

Read the full market overview

The North America market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Medical Cold Plasma is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Cold Plasma market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Cold Plasma market include Apyx Medical, Terraplasma Medical, Wacker Chemie, Neoplas Tools, ADTEC Plasma Technology, Plasmatreat GmbH, Relyon Plasma GmbH, Cinogy GmbH and Plasma Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Cold Plasma market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Cold Plasma and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Cold Plasma sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Cold Plasma market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Cold Plasma Segment by Company

Apyx Medical

Terraplasma Medical

Wacker Chemie

Neoplas Tools

ADTEC Plasma Technology

Plasmatreat GmbH

Relyon Plasma GmbH

Cinogy GmbH

Plasma Bioscience

PlasmaMed

Nova Plasma

Medical Cold Plasma Segment by Type

Microwave Plasma

Radio Frequency Plasma

Direct Current Plasma

Medical Cold Plasma Segment by Application

Sterilization and Disinfection

Coagulation and Hemostasis

Dental Applications

Wound Healing

Dermatology Treatment

Beauty and Skin Care

Tumor Treatment

Transfection and Drug Delivery

Material Surface Modification

Medical Cold Plasma Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Cold Plasma status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Cold Plasma market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Cold Plasma significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Cold Plasma competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Cold Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Cold Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Cold Plasma.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Cold Plasma market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Cold Plasma industry.

Chapter 3: Detailed analysis of Medical Cold Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Cold Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Cold Plasma in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Cold Plasma Industry Trends Table 2. Medical Cold Plasma Industry Drivers Table 3. Medical Cold Plasma Industry Opportunities and Challenges Table 4. Medical Cold Plasma Industry Restraints Table 5. Global Medical Cold Plasma Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Cold Plasma Revenue Share by Company (2021-2026) Table 7. Global Medical Cold Plasma Sales Volume by Company (Units) & (2021-2026) Table 8. Global Medical Cold Plasma Sales Volume Share by Company (2021-2026) Table 9. Global Medical Cold Plasma Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Medical Cold Plasma Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Cold Plasma Key Company Manufacturing Base & Headquarters Table 12. Global Medical Cold Plasma Company, Product Type & Application Table 13. Global Medical Cold Plasma Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Cold Plasma by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microwave Plasma Table 18. Significant Companies of Radio Frequency Plasma Table 19. Significant Companies of Direct Current Plasma Table 20. Global Medical Cold Plasma Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Medical Cold Plasma Sales Volume by Type (2021-2026) & (Units) Table 22. Global Medical Cold Plasma Sales Volume by Type (2027-2032) & (Units) Table 23. Global Medical Cold Plasma Sales Volume Share by Type (2021-2026) Table 24. Global Medical Cold Plasma Sales Volume Share by Type (2027-2032) Table 25. Global Medical Cold Plasma Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Cold Plasma Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Medical Cold Plasma Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Medical Cold Plasma Sales Value Share by Type (2021-2026) Table 29. Global Medical Cold Plasma Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Sterilization and Disinfection Table 31. Significant Companies of Coagulation and Hemostasis Table 32. Significant Companies of Dental Applications Table 33. Significant Companies of Wound Healing Table 34. Significant Companies of Dermatology Treatment Table 35. Significant Companies of Beauty and Skin Care Table 36. Significant Companies of Tumor Treatment Table 37. Significant Companies of Transfection and Drug Delivery Table 38. Significant Companies of Material Surface Modification Table 39. Global Medical Cold Plasma Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 40. Global Medical Cold Plasma Sales Volume by Application (2021-2026) & (Units) Table 41. Global Medical Cold Plasma Sales Volume by Application (2027-2032) & (Units) Table 42. Global Medical Cold Plasma Sales Volume Share by Application (2021-2026) Table 43. Global Medical Cold Plasma Sales Volume Share by Application (2027-2032) Table 44. Global Medical Cold Plasma Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Medical Cold Plasma Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Medical Cold Plasma Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Medical Cold Plasma Sales Value Share by Application (2021-2026) Table 48. Global Medical Cold Plasma Sales Value Share by Application (2027-2032) Table 49. Global Medical Cold Plasma Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 50. Global Medical Cold Plasma Sales by Region (2021-2026) & (Units) Table 51. Global Medical Cold Plasma Sales Market Share by Region (2021-2026) Table 52. Global Medical Cold Plasma Sales by Region (2027-2032) & (Units) Table 53. Global Medical Cold Plasma Sales Market Share by Region (2027-2032) Table 54. Global Medical Cold Plasma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Medical Cold Plasma Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Medical Cold Plasma Sales Value Share by Region (2021-2026) Table 57. Global Medical Cold Plasma Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Medical Cold Plasma Sales Value Share by Region (2027-2032) Table 59. Global Medical Cold Plasma Market Average Price (US$/Unit) by Region (2021-2026) Table 60. Global Medical Cold Plasma Market Average Price (US$/Unit) by Region (2027-2032) Table 61. Global Medical Cold Plasma Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 62. Global Medical Cold Plasma Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Medical Cold Plasma Sales by Country (2021-2026) & (Units) Table 64. Global Medical Cold Plasma Sales Market Share by Country (2021-2026) Table 65. Global Medical Cold Plasma Sales by Country (2027-2032) & (Units) Table 66. Global Medical Cold Plasma Sales Market Share by Country (2027-2032) Table 67. Global Medical Cold Plasma Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Medical Cold Plasma Sales Value Market Share by Country (2021-2026) Table 69. Global Medical Cold Plasma Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Medical Cold Plasma Sales Value Market Share by Country (2027-2032) Table 71. Apyx Medical Company Information Table 72. Apyx Medical Business Overview Table 73. Apyx Medical Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Apyx Medical Medical Cold Plasma Product Portfolio Table 75. Apyx Medical Recent Development Table 76. Terraplasma Medical Company Information Table 77. Terraplasma Medical Business Overview Table 78. Terraplasma Medical Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Terraplasma Medical Medical Cold Plasma Product Portfolio Table 80. Terraplasma Medical Recent Development Table 81. Wacker Chemie Company Information Table 82. Wacker Chemie Business Overview Table 83. Wacker Chemie Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Wacker Chemie Medical Cold Plasma Product Portfolio Table 85. Wacker Chemie Recent Development Table 86. Neoplas Tools Company Information Table 87. Neoplas Tools Business Overview Table 88. Neoplas Tools Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Neoplas Tools Medical Cold Plasma Product Portfolio Table 90. Neoplas Tools Recent Development Table 91. ADTEC Plasma Technology Company Information Table 92. ADTEC Plasma Technology Business Overview Table 93. ADTEC Plasma Technology Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. ADTEC Plasma Technology Medical Cold Plasma Product Portfolio Table 95. ADTEC Plasma Technology Recent Development Table 96. Plasmatreat GmbH Company Information Table 97. Plasmatreat GmbH Business Overview Table 98. Plasmatreat GmbH Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Plasmatreat GmbH Medical Cold Plasma Product Portfolio Table 100. Plasmatreat GmbH Recent Development Table 101. Relyon Plasma GmbH Company Information Table 102. Relyon Plasma GmbH Business Overview Table 103. Relyon Plasma GmbH Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Relyon Plasma GmbH Medical Cold Plasma Product Portfolio Table 105. Relyon Plasma GmbH Recent Development Table 106. Cinogy GmbH Company Information Table 107. Cinogy GmbH Business Overview Table 108. Cinogy GmbH Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Cinogy GmbH Medical Cold Plasma Product Portfolio Table 110. Cinogy GmbH Recent Development Table 111. Plasma Bioscience Company Information Table 112. Plasma Bioscience Business Overview Table 113. Plasma Bioscience Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Plasma Bioscience Medical Cold Plasma Product Portfolio Table 115. Plasma Bioscience Recent Development Table 116. PlasmaMed Company Information Table 117. PlasmaMed Business Overview Table 118. PlasmaMed Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. PlasmaMed Medical Cold Plasma Product Portfolio Table 120. PlasmaMed Recent Development Table 121. Nova Plasma Company Information Table 122. Nova Plasma Business Overview Table 123. Nova Plasma Medical Cold Plasma Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Nova Plasma Medical Cold Plasma Product Portfolio Table 125. Nova Plasma Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Medical Cold Plasma Distributors List Table 129. Medical Cold Plasma Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Medical Cold Plasma Product Image Figure 2. Global Medical Cold Plasma Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Cold Plasma Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Cold Plasma Sales (2021-2032) & (Units) Figure 5. Global Medical Cold Plasma Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Medical Cold Plasma Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microwave Plasma Image Figure 10. Radio Frequency Plasma Image Figure 11. Direct Current Plasma Image Figure 12. Global Medical Cold Plasma Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Medical Cold Plasma Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Cold Plasma Sales Volume Share by Type (2021-2032) Figure 15. Global Medical Cold Plasma Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medical Cold Plasma Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Cold Plasma Sales Value Share by Type (2021-2032) Figure 18. Sterilization and Disinfection Image Figure 19. Coagulation and Hemostasis Image Figure 20. Dental Applications Image Figure 21. Wound Healing Image Figure 22. Dermatology Treatment Image Figure 23. Beauty and Skin Care Image Figure 24. Tumor Treatment Image Figure 25. Transfection and Drug Delivery Image Figure 26. Material Surface Modification Image Figure 27. Global Medical Cold Plasma Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 28. Global Medical Cold Plasma Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Medical Cold Plasma Sales Volume Share by Application (2021-2032) Figure 30. Global Medical Cold Plasma Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Medical Cold Plasma Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Medical Cold Plasma Sales Value Share by Application (2021-2032) Figure 33. Global Medical Cold Plasma Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 34. Global Medical Cold Plasma Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Medical Cold Plasma Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Medical Cold Plasma Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Medical Cold Plasma Sales Value (2021-2032) & (US$ Million) Figure 38. North America Medical Cold Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Medical Cold Plasma Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Medical Cold Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Medical Cold Plasma Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Medical Cold Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Medical Cold Plasma Sales Value (2021-2032) & (US$ Million) Figure 44. South America Medical Cold Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Medical Cold Plasma Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Medical Cold Plasma Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Medical Cold Plasma Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Medical Cold Plasma Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Medical Cold Plasma Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Microwave Plasma
  • Radio Frequency Plasma
  • Direct Current Plasma
Applications
  • Sterilization and Disinfection
  • Coagulation and Hemostasis
  • Dental Applications
  • Wound Healing
  • Dermatology Treatment
  • Beauty and Skin Care
  • Tumor Treatment
  • Transfection and Drug Delivery
  • Material Surface Modification
Companies covered
  • Apyx Medical
  • Terraplasma Medical
  • Wacker Chemie
  • Neoplas Tools
  • ADTEC Plasma Technology
  • Plasmatreat GmbH
  • Relyon Plasma GmbH
  • Cinogy GmbH
  • Plasma Bioscience
  • PlasmaMed
  • Nova Plasma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Cold Plasma Sales Value (2021-2032)
  4. 1.2.2 Global Medical Cold Plasma Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Cold Plasma Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Cold Plasma Market Dynamics
  1. 2.1 Medical Cold Plasma Industry Trends
  2. 2.2 Medical Cold Plasma Industry Drivers
  3. 2.3 Medical Cold Plasma Industry Opportunities and Challenges
  4. 2.4 Medical Cold Plasma Industry Restraints
3 Medical Cold Plasma Market by Company
  1. 3.1 Global Medical Cold Plasma Company Revenue Ranking in 2025
  2. 3.2 Global Medical Cold Plasma Revenue by Company (2021-2026)
  3. 3.3 Global Medical Cold Plasma Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Cold Plasma Average Price by Company (2021-2026)
  5. 3.5 Global Medical Cold Plasma Company Ranking (2024-2026)
  6. 3.6 Global Medical Cold Plasma Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Cold Plasma Company Product Type and Application
  8. 3.8 Global Medical Cold Plasma Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Cold Plasma Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Cold Plasma Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Cold Plasma Market by Type
  1. 4.1 Medical Cold Plasma Type Introduction
  2. 4.1.1 Microwave Plasma
  3. 4.1.2 Radio Frequency Plasma
  4. 4.1.3 Direct Current Plasma
  5. 4.2 Global Medical Cold Plasma Sales Volume by Type
  6. 4.2.1 Global Medical Cold Plasma Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Cold Plasma Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Medical Cold Plasma Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Medical Cold Plasma Sales Value by Type
  10. 4.3.1 Global Medical Cold Plasma Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Medical Cold Plasma Sales Value by Type (2021-2032)
  12. 4.3.3 Global Medical Cold Plasma Sales Value Share by Type (2021-2032)
5 Medical Cold Plasma Market by Application
  1. 5.1 Medical Cold Plasma Application Introduction
  2. 5.1.1 Sterilization and Disinfection
  3. 5.1.2 Coagulation and Hemostasis
  4. 5.1.3 Dental Applications
  5. 5.1.4 Wound Healing
  6. 5.1.5 Dermatology Treatment
  7. 5.1.6 Beauty and Skin Care
  8. 5.1.7 Tumor Treatment
  9. 5.1.8 Transfection and Drug Delivery
  10. 5.1.9 Material Surface Modification
  11. 5.2 Global Medical Cold Plasma Sales Volume by Application
  12. 5.2.1 Global Medical Cold Plasma Sales Volume by Application (2021 VS 2025 VS 2032)
  13. 5.2.2 Global Medical Cold Plasma Sales Volume by Application (2021-2032)
  14. 5.2.3 Global Medical Cold Plasma Sales Volume Share by Application (2021-2032)
  15. 5.3 Global Medical Cold Plasma Sales Value by Application
  16. 5.3.1 Global Medical Cold Plasma Sales Value by Application (2021 VS 2025 VS 2032)
  17. 5.3.2 Global Medical Cold Plasma Sales Value by Application (2021-2032)
  18. 5.3.3 Global Medical Cold Plasma Sales Value Share by Application (2021-2032)
6 Medical Cold Plasma Regional Sales and Value Analysis
  1. 6.1 Global Medical Cold Plasma Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Cold Plasma Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Cold Plasma Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Cold Plasma Sales by Region (2027-2032)
  5. 6.3 Global Medical Cold Plasma Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Cold Plasma Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Cold Plasma Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Cold Plasma Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Cold Plasma Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Cold Plasma Sales Value (2021-2032)
  12. 6.6.2 North America Medical Cold Plasma Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Cold Plasma Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Cold Plasma Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Cold Plasma Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Cold Plasma Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Cold Plasma Sales Value (2021-2032)
  21. 6.9.2 South America Medical Cold Plasma Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Cold Plasma Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Cold Plasma Sales Value Share by Country, 2025 VS 2032
7 Medical Cold Plasma Country-level Sales and Value Analysis
  1. 7.1 Global Medical Cold Plasma Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Cold Plasma Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Cold Plasma Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Cold Plasma Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Cold Plasma Sales by Country (2027-2032)
  6. 7.4 Global Medical Cold Plasma Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Cold Plasma Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Cold Plasma Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Cold Plasma Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Cold Plasma Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Cold Plasma Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Apyx Medical
  2. 8.1.1 Apyx Medical Company Information
  3. 8.1.2 Apyx Medical Business Overview
  4. 8.1.3 Apyx Medical Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Apyx Medical Medical Cold Plasma Product Portfolio
  6. 8.1.5 Apyx Medical Recent Developments
  7. 8.2 Terraplasma Medical
  8. 8.2.1 Terraplasma Medical Company Information
  9. 8.2.2 Terraplasma Medical Business Overview
  10. 8.2.3 Terraplasma Medical Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Terraplasma Medical Medical Cold Plasma Product Portfolio
  12. 8.2.5 Terraplasma Medical Recent Developments
  13. 8.3 Wacker Chemie
  14. 8.3.1 Wacker Chemie Company Information
  15. 8.3.2 Wacker Chemie Business Overview
  16. 8.3.3 Wacker Chemie Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wacker Chemie Medical Cold Plasma Product Portfolio
  18. 8.3.5 Wacker Chemie Recent Developments
  19. 8.4 Neoplas Tools
  20. 8.4.1 Neoplas Tools Company Information
  21. 8.4.2 Neoplas Tools Business Overview
  22. 8.4.3 Neoplas Tools Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Neoplas Tools Medical Cold Plasma Product Portfolio
  24. 8.4.5 Neoplas Tools Recent Developments
  25. 8.5 ADTEC Plasma Technology
  26. 8.5.1 ADTEC Plasma Technology Company Information
  27. 8.5.2 ADTEC Plasma Technology Business Overview
  28. 8.5.3 ADTEC Plasma Technology Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ADTEC Plasma Technology Medical Cold Plasma Product Portfolio
  30. 8.5.5 ADTEC Plasma Technology Recent Developments
  31. 8.6 Plasmatreat GmbH
  32. 8.6.1 Plasmatreat GmbH Company Information
  33. 8.6.2 Plasmatreat GmbH Business Overview
  34. 8.6.3 Plasmatreat GmbH Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Plasmatreat GmbH Medical Cold Plasma Product Portfolio
  36. 8.6.5 Plasmatreat GmbH Recent Developments
  37. 8.7 Relyon Plasma GmbH
  38. 8.7.1 Relyon Plasma GmbH Company Information
  39. 8.7.2 Relyon Plasma GmbH Business Overview
  40. 8.7.3 Relyon Plasma GmbH Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Relyon Plasma GmbH Medical Cold Plasma Product Portfolio
  42. 8.7.5 Relyon Plasma GmbH Recent Developments
  43. 8.8 Cinogy GmbH
  44. 8.8.1 Cinogy GmbH Company Information
  45. 8.8.2 Cinogy GmbH Business Overview
  46. 8.8.3 Cinogy GmbH Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cinogy GmbH Medical Cold Plasma Product Portfolio
  48. 8.8.5 Cinogy GmbH Recent Developments
  49. 8.9 Plasma Bioscience
  50. 8.9.1 Plasma Bioscience Company Information
  51. 8.9.2 Plasma Bioscience Business Overview
  52. 8.9.3 Plasma Bioscience Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Plasma Bioscience Medical Cold Plasma Product Portfolio
  54. 8.9.5 Plasma Bioscience Recent Developments
  55. 8.10 PlasmaMed
  56. 8.10.1 PlasmaMed Company Information
  57. 8.10.2 PlasmaMed Business Overview
  58. 8.10.3 PlasmaMed Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 PlasmaMed Medical Cold Plasma Product Portfolio
  60. 8.10.5 PlasmaMed Recent Developments
  61. 8.11 Nova Plasma
  62. 8.11.1 Nova Plasma Company Information
  63. 8.11.2 Nova Plasma Business Overview
  64. 8.11.3 Nova Plasma Medical Cold Plasma Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nova Plasma Medical Cold Plasma Product Portfolio
  66. 8.11.5 Nova Plasma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Cold Plasma Value Chain Analysis
  2. 9.1.1 Medical Cold Plasma Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Cold Plasma Sales Mode & Process
  6. 9.2 Medical Cold Plasma Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Cold Plasma Distributors
  9. 9.2.3 Medical Cold Plasma Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst